as on October 4, 2025 at 1:23 am IST
Day's High
7.91%
Upside
52 Week's Low
52 Week's High
29.38%
Downside
1594.92%
Upside
Check Propanc Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.6M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
4340300.00%
Compare market cap, revenue, PE, and other key metrics of Propanc Biopharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $23.6M | NA | NA | 0.00% | |
NA | $40.5B | NA | NA | -3.89% | |
BUY | $60.4B | 236.34% | -505.15 | -12.96% | |
BUY | $104.8B | 54.64% | 29.06 | 31.86% | |
BUY | $63.6B | 6.23% | 15.13 | 31.37% |
The Propanc Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Propanc Biopharma Inc investment value today
Current value as on today
₹17,573
Returns
Returns from Propanc Biopharma Inc Stock
Dollar Returns*
₹5,773 (+5.77%)
Search interest for Propanc Biopharma Inc Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Beone Medicines Ltd has given 127.8% return, outperforming this stock by 227.8%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.9% return, outperforming this stock by 158.5%
Price Dip
In the last 7 days, PPCB stock has moved down by -6.1%
Organisation | Propanc Biopharma Inc |
Headquarters | 302, 6 Butler Street, Camberwell, VIC, Australia, 3124 |
CEO | Mr. James Nathanielsz |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. James Nathanielsz | CEO & Executive Chairman |
Dr. Julian Norman Kenyon ChB, M.D., MB | Chief Scientific Officer & Director |
Ms. Jeannine Zimmerman | Chief Financial Officer |
Prof. Klaus Kutz M.D. | Chief Medical Officer & Member of Scientific Advisory Board |
Propanc Biopharma Inc share price today is $1.77 as on at the close of the market. Propanc Biopharma Inc share today touched a day high of $1.91 and a low of $1.77.
Propanc Biopharma Inc share touched a 52 week high of $30 on and a 52 week low of $1.25 on . Propanc Biopharma Inc stock price today i.e. is closed at $1.77,which is 94.10% down from its 52 week high and 41.60% up from its 52 week low.
Propanc Biopharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Propanc Biopharma Inc (PPCB) shares with as little as ₹88.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.75 in Propanc Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Propanc Biopharma Inc share’s latest price of $1.77 as on October 4, 2025 at 1:23 am IST, you will get 5.6497 shares of Propanc Biopharma Inc. Learn more about
fractional shares .